Tempest Therapeutics Statistics
Total Valuation
TPST has a market cap or net worth of $31.14 million. The enterprise value is $32.03 million.
Important Dates
The next estimated earnings date is Thursday, March 26, 2026, after market close.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPST has 13.48 million shares outstanding. The number of shares has increased by 114.19% in one year.
| Current Share Class | 13.48M |
| Shares Outstanding | 13.48M |
| Shares Change (YoY) | +114.19% |
| Shares Change (QoQ) | +16.75% |
| Owned by Insiders (%) | 35.93% |
| Owned by Institutions (%) | 5.56% |
| Float | 8.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.62 |
| P/TBV Ratio | 4.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 1.32.
| Current Ratio | 2.30 |
| Quick Ratio | 2.13 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -80.21 |
Financial Efficiency
Return on equity (ROE) is -405.03% and return on invested capital (ROIC) is -103.58%.
| Return on Equity (ROE) | -405.03% |
| Return on Assets (ROA) | -89.32% |
| Return on Invested Capital (ROIC) | -103.58% |
| Return on Capital Employed (ROCE) | -267.69% |
| Weighted Average Cost of Capital (WACC) | -5.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.29% in the last 52 weeks. The beta is -2.18, so TPST's price volatility has been lower than the market average.
| Beta (5Y) | -2.18 |
| 52-Week Price Change | -78.29% |
| 50-Day Moving Average | 2.60 |
| 200-Day Moving Average | 6.58 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 82,802 |
Short Selling Information
The latest short interest is 192,674, so 1.43% of the outstanding shares have been sold short.
| Short Interest | 192,674 |
| Short Previous Month | 144,511 |
| Short % of Shares Out | 1.43% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 1.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.42M |
| Pretax Income | -36.05M |
| Net Income | -36.05M |
| EBITDA | -36.17M |
| EBIT | -36.42M |
| Earnings Per Share (EPS) | -$9.71 |
Full Income Statement Balance Sheet
The company has $7.51 million in cash and $8.41 million in debt, with a net cash position of -$891,000 or -$0.07 per share.
| Cash & Cash Equivalents | 7.51M |
| Total Debt | 8.41M |
| Net Cash | -891,000 |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | 6.35M |
| Book Value Per Share | 1.43 |
| Working Capital | 4.58M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$33.40 million and capital expenditures -$3,000, giving a free cash flow of -$33.40 million.
| Operating Cash Flow | -33.40M |
| Capital Expenditures | -3,000 |
| Free Cash Flow | -33.40M |
| FCF Per Share | -$2.48 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -114.19% |
| Shareholder Yield | -114.19% |
| Earnings Yield | -115.78% |
| FCF Yield | -107.25% |
Analyst Forecast
The average price target for TPST is $10.00, which is 332.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 332.90% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:13.
| Last Split Date | Apr 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:13 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |